UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment

Annals of oncology, 2022-11, Vol.33 (11), p.1207-1208

2022

Volltextzugriff (PDF)

Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection

Medical microbiology and immunology, 2022-12, Vol.211 (5-6), p.249-260

2022

Volltextzugriff (PDF)

Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy

Journal of clinical virology, 2016-08, Vol.81, p.16-24

2016

Volltextzugriff (PDF)

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood

BJOG : an international journal of obstetrics and gynaecology, 2011-03, Vol.118 (4), p.448-456

2011

Volltextzugriff (PDF)

SARS‐CoV‐2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

Journal of the European Academy of Dermatology and Venereology, 2022-02, Vol.36 (2), p.e86-e88

2022

Volltextzugriff (PDF)

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

American journal of transplantation, 2011-11, Vol.11 (11), p.2463-2471

2011

Volltextzugriff (PDF)

Incidence of human cytomegalovirus infection and T-cell response in patients with psoriasis before and during antitumour necrosis factor-[alpha] therapy

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.e323

2017

Volltextzugriff (PDF)

Incidence of human cytomegalovirus infection and T‐cell response in patients with psoriasis before and during antitumour necrosis factor‐α therapy

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.e323-e324

2017

Volltextzugriff (PDF)

Monitoring of Human Cytomegalovirus‐Specific CD4+ and CD8+ T‐Cell Immunity in Patients Receiving Solid Organ Transplantation

American journal of transplantation, 2006-10, Vol.6 (10), p.2356-2364

2006

Volltextzugriff (PDF)

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

ESMO open, 2021-10, Vol.6 (5), p.100272-100272, Article 100272

2021

Volltextzugriff (PDF)

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study

ESMO open, 2022-04, Vol.7 (2), p.100458, Article 100458

2022

Volltextzugriff (PDF)

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern

ESMO open, 2022-10, Vol.7 (5), p.100574-100574, Article 100574

2022

Volltextzugriff (PDF)

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up

ESMO open, 2022-02, Vol.7 (1), p.100359-100359, Article 100359

2022

Volltextzugriff (PDF)

Inconsistent Responses of Cytomegalovirus‐Specific T Cells to pp65 and IE‐1 versus Infected Dendritic Cells in Organ Transplant Recipients

American journal of transplantation, 2007-08, Vol.7 (8), p.1997-2005

2007

Volltextzugriff (PDF)

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.873-879

2008

Volltextzugriff (PDF)

Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons

Archives of virology, 2005-11, Vol.150 (11), p.2365-2375

2005

Volltextzugriff (PDF)

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

The New England journal of medicine, 2014-04, Vol.370 (14), p.1316-1326

2014

Volltextzugriff (PDF)

In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells

Journal of general virology, 2001-06, Vol.82 (6), p.1429-1438

2001

Volltextzugriff (PDF)

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Transplantation, 2013-08, Vol.96 (4), p.333

2013

Volltextzugriff (PDF)

170 Specific Anti-CMV Reactivity in BAL: A Useful Tool

The Journal of heart and lung transplantation, 2011, Vol.30 (4), p.S63-S63

2011

Volltextzugriff (PDF)

New advances in CMV and immunosenescence

Experimental gerontology, 2014-07, Vol.55, p.54-62

2014

Volltextzugriff (PDF)

Chronic Lung Allograft Dysfunction is Associated with Acute Rejection and High Levels of Cytomegalovirus Load in Blood (but Not in Lung)

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S336-S337

2021

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779

2010

Volltextzugriff (PDF)

Immunosuppressive Treatment Does Not Prevent Humoral and Cellular Virus-Specific Immunity in Heart or Lung Recipients with SARS-CoV-2 Pneumonia

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S145-S145

2021

Volltextzugriff (PDF)

Monitoring human cytomegalovirus infection in transplant recipients

Journal of clinical virology, 2008-03, Vol.41 (3), p.237-241

2008

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(57)
Humans
(56)
Human Cytomegalovirus
(35)
Biological And Medical Sciences
(30)
Medical Sciences
(28)
Adult
(27)
Female
(24)
Infectious Diseases
(24)
Microbiology
(23)
Cytomegalovirus Infections - Virology
(22)
Immunology
(21)
Middle Aged
(21)
Cytomegalovirus - Immunology
(20)
Cytomegalovirus Infections - Immunology
(20)
Male
(20)
Virology
(19)
Cytomegalovirus
(18)
Viral Diseases
(17)
Cytomegalovirus Infections - Diagnosis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment

Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection

Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood

SARS‐CoV‐2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

Incidence of human cytomegalovirus infection and T-cell response in patients with psoriasis before and during antitumour necrosis factor-[alpha] therapy

Incidence of human cytomegalovirus infection and T‐cell response in patients with psoriasis before and during antitumour necrosis factor‐α therapy

Monitoring of Human Cytomegalovirus‐Specific CD4+ and CD8+ T‐Cell Immunity in Patients Receiving Solid Organ Transplantation

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up

Inconsistent Responses of Cytomegalovirus‐Specific T Cells to pp65 and IE‐1 versus Infected Dendritic Cells in Organ Transplant Recipients

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

170 Specific Anti-CMV Reactivity in BAL: A Useful Tool

New advances in CMV and immunosenescence

Chronic Lung Allograft Dysfunction is Associated with Acute Rejection and High Levels of Cytomegalovirus Load in Blood (but Not in Lung)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Immunosuppressive Treatment Does Not Prevent Humoral and Cellular Virus-Specific Immunity in Heart or Lung Recipients with SARS-CoV-2 Pneumonia

Monitoring human cytomegalovirus infection in transplant recipients

Suchergebnisse filtern